猪生长激素基因表达质粒的构建及其转基因动物研究

将猪生长激素基因（ＰＧＨ）克隆到质粒ｐＵＣ１９上,经酶切分析,确定其酶切图谱。把ＰＧＨ转录起始位点以前的序列切掉,换上羊ＭＴ－１ａ基因的启动子,构建成可以调控的表达载体ｐＳＭＴＰＧＨ,用于转基因动物的研究。采用微注射法将线状ｐＳＭＴＰＧＨ导入猪、鼠和金鱼的受精卵中,得到了相应的转基因动物。对这些动物鉴定分析表明,外源基因整合率因动物不同而异,但该基因在这３种动物中的整合率均在９％以上,其生长速度都     

Localization of An Exogenous GH Gene on Chromosomes of Transgenic Pig by in situ Hybridizaiton

近些年来随着原位杂交技术的不断改进,该技术已广泛用于染色体的基因定位。非放射性标记探针的应用使基因定位变得更加简单易行,从而有可能对动物的转基因进行定位研究。本文首次采用胶体金标记药盒（Ａｎｔｉｄｉｇｏｘｉｇｅｎｉｎｇｏｌｄ）和银加强试剂（Ｓｉｌｖｅｒｅｎｈａｎｃｅｍｅｎｔｒｅａｇｅｎｔｓ）的非同位素原位杂交技术对转基因猪外源基因进行了定位研究。如Ｆｉｇ．１所示：表达质粒ｐＳＭＴＰＧＨ含有载体ｐＵＣ１９,羊启动子ＭＴ０１１和猪生长激素ＰＧＨ基因。选５头带有ｐＳＭＴＰＧＨ的转基因猪,分别制备含有染色体ＤＮＡ的杂交膜。用ＢｇｌＩＩ和ＳｍａＩ对ｐＳＭＴＰＧＨ进行完全酶切,收集０．９Ｋｂ片段作为探针,以ｄｉｇ１１ｄＵＴＰ进行标记。探针与ＤＮＡ杂交后,用Ａｎｔｉｄｉｇｏｘｉｇｅｎｉｎｇｏｌｄ和Ｓｉｌｖｅｒｅｎｈａｎｃｅｍｅｎｔｒｅａｇｅｎｔｓ进行显色反应。胰酶法Ｇ—显带后,用光学显微镜检查。选择分散相良好、显影银颗粒清楚的玻片进行摄影记录（Ｆｉｇ．２）。对染色体上的显影银颗粒进行统计分析,参照家猪的染色体标准带型,确定外源ＰＧＨ基因整合位点。Ｆｉｇ．３为４１０４号转基因猪染色体上的银颗粒分布情况。对５头     

绿色荧光蛋白基因在青蒿转基因芽中的表达

将改良的绿色荧光蛋白（ＧＦＰ）基因,插入到植物表达载体中,构建双ＣａＭＶ３５Ｓ启动子驱动下的植物表达载体ｐＢＩＧＦＰ,在Ｋａｍ浓度为２０ｍｇ／Ｌ的筛选培养基上,用含有ｐＢＩＦＰ质粒的根癌农杆菌ＬＢＡ４４０４感染青蒿叶片,获得５个抗Ｋａｎ阳性丛生芽系。Ｓｏｕｔｈｅｒｎ ｂｌｏｔｔｉｎｇ分析表明,外源ＧＦＰ基因已整合到青蒿转基因芽Ｇ－１系的基因组中。在ＯＬＹＭＰＵＳ－ＢＨ２型荧光显微镜下,观察到转基因     

转OMT／PGH基因猪外源基因整合及遗传特性研究

实验以转ＯＭＴ／ＰＧＨ基因猪的Ｇ０,Ｇ１,Ｇ２和Ｇ３代共８头猪为材料,应用同位素和非同位素标记的染色体原位杂交技术,对外源ＯＭＴ／ＰＧＨ基因在猪染色体上整合位点进行研究,结果表明：（１）外源基因可以整合在染色体上,整合的位点是随机的。（２）整合在染色体上的外源基因可以遗传给子代;（３）整合在染色体上的外源基因在转基因动物世代过程中整合的位点是相对稳定的。     

Studies on Pattern of Producing Transgenic Fish I.Production and Detection of All fish TRansgenic Common Carp With cMT sGH Gene

转基因鱼工作的开展被用于水产科学基础与应用研究的各个领域。应用方面的一项重要研究就是利用转生长激素基因来提高鱼的增长速度。需要解决两个问题：一是转基因鱼所使用的基因元件;二是外源基因的高整和率与高表达。已有许多报道认为：不同种动物的生长激素不一定相互促进生长。我们通过显微注射,将鲤鱼金属硫蛋白启动子（ｃＭＴ）与大马哈鱼生长激素基因（ｓＧＨ）的融合基因（ｃＭＴｓＧＨ）导入鲤鱼单细胞后期的早期胚胎,构建了全鱼转基因鲤鱼。通过斑点杂交、Ｓｏｕｔｈｅｒｎｂｌｏｔ结合ＰＣＲＳｏｕｔｈｅｒｎｂｌｏｔ,对外源ｓＧＨ的整和进行了精确的检测和分析。实验选取性成熟鲤鱼,收集卵子和精子,湿法受精获得受精卵。经过基因注射,孵化后的鱼苗放入水族箱。待鱼苗平游,提取总ＤＮＡ进行检测。以ＰｓｔＩ酶切质粒ｐｃＭＴｃＧＨ（Ｆｉｇ．４）分离３．４ＫｂｓＧＨ片段,用随机引物标记,作为杂交探针。同时,设计并合成ｓＧＨ基因的ＰＣＲ特异引物。Ｆｉｇ．１的斑点杂交结果与Ｆｉｇ．２的ＰＣＲＳｏｕｔｈｅｒｎ结果相比较（Ｔａｂｌｅ１）,说明斑点杂交存在着高的假阳性。而ＰＣＲＳｏｕｔｈｅｒｎ将ＰＣＲ的快速、方便与Ｓｏｕｔｈｅｒｎ的准确性相结合,排除了Ｐ     

人血小板生成素受体c—MPL膜内部分的聚合作用

血小板生成素（ＴＰＯ）是调节血小板生成最主要的细胞因子,其生物学效应由其受体ｃ－ＭＰＬ介导。利用酵母双杂合系统研究ｃ－ＭＰＬ膜内部分在ＴＰＯ信号转导途径中的功能。首先用反转录ＰＣＲ（ＲＴ－ＰＣＲ）方法从人红白血病ＨＥＬ细胞系总ＲＮＡ中扩增并克隆Ｐ型ｃ－ＭＰＬ（ＭＰＬＰ）膜内部分ｃＤＮＡ,经测序验证后克隆至双杂合载体ｐＡＳ２和ｐＧＡＤ４２４中,重组质粒命名为ｐＡＳＭＭ和ｐＧＡＤＭＭ。将ｐＡＳＭＭ与ｐ     

日本血吸虫26kD抗原基因在BCG中的表达

研究了外源基因日本血吸虫２６ｋＤ抗原（Ｓｊ２６ＧＳＴ）在卡介苗（ｂａｃｉｌｕｓＣａｌｍｅｔｅ－Ｇｕｅｒｉｎ,ＢＣＧ）、耻垢分枝杆菌（Ｍ．ｓｍｅｇｍａｔｉｓ）和大肠杆菌（Ｅ．ｃｏｌｉ）中的表达．运用重组ＤＮＡ和聚合酶链反应（ＰＣＲ）等分子生物学技术,以表达Ｓｊ２６ＧＳＴ的Ｅ．ｃｏｌｉｐＧＥＸ衍生质粒为模板,经ＰＣＲ得到编码Ｓｊ２６ＧＳＴ的全长ｃＤＮＡ片段．将其按正确的阅读框顺序,克隆到人结核杆菌热休克蛋白（ｈｅａｔｓｈｏｃｋｐｒｏｔｅｉｎ,ＨＳＰ）７０的启动子下游,再将ＨＳＰ７０启动子和Ｓｊ２６ＧＳＴ基因一起亚克隆到Ｅ．ｃｏｌｉ－分枝杆菌穿梭质粒ｐＢＣＧ－２０００中,得到Ｅ．ｃｏｌｉ－分枝杆菌穿梭表达质粒ｐＢＣＧ－Ｓｊ２６．ｐＢＣＧ－Ｓｊ２６电转化入ＢＣＧ和Ｍ．ｓｍｅｇｍａｔｉｓｍｃ２１５５中表达Ｓｊ２６ＧＳＴ抗原,所表达的天然重组Ｓｊ２６ＧＳＴ（ｒＳｊ２６ＧＳＴ）为可溶性蛋白,在ＳＤＳ－ＰＡＧＥ上分子量为２６ｋＤ处可见明显的表达蛋白带．其表达量分别占ＢＣＧ和Ｍ．ｓｍｅｇｍａｔｉｓ菌体总蛋白的１５％和１０％．可见,Ｓｊ２６ＧＳＴ基因能在ＢＣＧ中高效表达．     

金属硫蛋白 - 潜伏膜蛋白融合基因的体外转录调控

ＥＢ病毒（ＥＢＶ）是一种与地区性伯基特氏淋巴瘤、鼻咽癌、何杰金氏病等多种人体肿瘤有关的疱疹病毒．已往的研究表明,潜伏膜蛋白（ＬＭＰ）基因是ＥＢＶ最可能的致瘤基因．为制备ＬＭＰ基因转基因小鼠,探讨ＬＭＰ的体内致瘤作用,首先构建了含鼠金属硫蛋白－１（ＭＴ－１）基因调控区和ＬＭＰ基因编码区的ｐＢＲ３２２－ＭＴ－ＬＭＰ质粒,并用电击法将该质粒与ｐＫＪ１－Ｎｅｏ质粒共转染人胃癌细胞株ＭＧＣ,对ＭＴ－ＬＭＰ基因在转染细胞中的整合、转录情况及重金属镉和镍对该融合基因的转录调控进行了研究．结果表明：（１）两质粒共转染效率为８６．７％;（２）ＰＣＲ和Ｓｏｕｔｈｅｒｎ杂交分析显示,完整的ＭＴ－ＬＭＰ基因已整合入转染的ＭＧＣ细胞基因组,且在不同的转染细胞克隆中,ＭＴ－ＬＭＰ基因整合的方式及拷贝数不同,拷贝数从１到１９不等;（３）ＲＴ－ＰＣＲ和Ｎｏｒｔｈｅｒｎ杂交分析证实,ＭＴ－ＬＭＰ基因不仅在转染的ＭＧＣ中能够转录,而且在１０μｍｏｌ／Ｌ镉诱导下,ＭＴ－ＬＭＰ基因转录增强,平均增高约１．４倍．结果说明,在ＭＴ－１基因调控区指导下,ＬＭＰ基因不但有ｍＲＮＡ水平的表达,而且其表达受重金属镉的调控,上述结果为制备ＭＴ－ＬＭＰ转基因小鼠     

利用瞬时表达系统研究马铃薯Y类病毒基因对豌豆Hsp70基因启动子激 …

建立了一个瞬时表达系统以研究豌豆种传花叶病毒（ＰＳｂＭＶ,一种马铃薯Ｙ类病毒）不同基因对豌豆（Ｐｉｓｕｍ ｓａｔｉｖｕｍ Ｌ．）Ｈｓｐ７０基因启动子激少能力的差划。构建了豌豆Ｈｓｐ７０基因启动子指导下的ＧＵＳ基因的表达载体,同时还制备了３５Ｓ启动子指导下的ＰＳｂＭＶ Ｐ１和Ｐ３基因的表达载体。以表达载体ＤＮＡ包被才金焰做子弹,利用基因枪对豌豆离体叶片进行共轰击实验,结果表明,ＰＳＢＭＶ Ｐ１和Ｐ３     

猪生长激素基因在杆状病毒载体系统中的表达

通过对猪生长激素（ｐＧＨ）基因的ｃＤＮＡ进行测序,得到ｐＧＨｃＤＮＡ的全序列,并与Ｓｅｅｂｕｒｇ等报道的序列进行了比较和讨论。然后利用具人工合成启动子和多角体蛋白ＸＩＶ启动子的转移载体质粒ｐＳＸＩＶＶＩ＾＋Ｘ３／４构建出含ｐＧＨ基因的重组质粒ｐＸ３／４－ｐＧＨ。将ｐＸ３／４－ｐＧＨ与致死缺失型线性化ＡｃＭＮＰＶ－ＯＣＣ＾－ＤＮＡ共转染Ｓｆ９细胞,构建出既能形成多角体又能表达ｐＧＨ基因的苜蓿丫纹夜蛾     

High-level expressing YAC vector for transgenic animal bioreactors

The position effect is one major problem in the production of transgenic animals as mammary gland bioreactors. In the present study, we introduced the human growth hormone (hGH) gene into 210-kb human alpha-lactalbumin position-independent YAC vectors using homologous recombination and produced transgenic rats via microinjection of YAC DNA into rat embryos. The efficiency of producing transgenic rats with the YAC vector DNA was the same as that using plasmid constructs. All analyzed transgenic rats had one copy of the transgene and produced milk containing a high level of hGH (0.25-8.9 mg/ml). In transgenic rats with the YAC vector in which the human alpha-lactalbumin gene was replaced with the hGH gene, tissue specificity of hGH mRNA was the same as that of the endogenous rat alpha-lactalbumin gene. Thus, the 210-kb human alpha-lactalbumin YAC is a useful vector for high-level expression of foreign genes in the milk of transgenic animals.     

Factors influencing efficient production of transgenic rabbits

Factors that influence the efficient production of transgenic rabbits are described. The effects of the number of embryos transferred to the recipient, of recipient age, of a variety of gene constructs and of a dual use of donors as recipients (donor-recipient (DR) method) were statistically evaluated from the data collected in three experiments with three different genes. Higher survival rates of microinjected embryos were obtained in younger recipients (6-17 months), while the rates were-markedly decreased in recipients over 18 months old. Integration efficiencies (transgenic rabbits per newborn) were significantly different from the gene constructs used, but not related to either the number of embryos transferred or the number of newborns obtained. No significant differences in the survival rate of embryos of injected embryos and the integration efficiency were observed in both the DR embryo transfer method and the traditional method using pseudopregnant recipients (PR). Our results suggest that the gene construct and the survival rate of injected embryos were important factors affecting the efficiency of producing transgenic rabbits, and the age of recipients was one of the important factors affecting the survival rate of the injected embryos. The DR method was useful for reducing the number of animals required for production of transgenic rabbits.     

The effect of coating single- and double-stranded DNA with the recombinase A protein of Escherichia coli on transgene integration in mice

Embryo survival and transgene integration rates are two major factors that influence the efficiency of transgenic animal production by pronuclear microinjection. Recombinase A protein-coated transgenes were compared for transgene integration and embryo survival with their non-coated counterparts in both single- and double-stranded forms. Murine zygotes were microinjected with a large 30 kb α_S1-casein/human lysozyme DNA construct and a small 5.5 kb β-lactoglobulin/desaturase DNA construct using four different construct preparations for each gene. The preparations included recombinase A protein-coated, single- and double-stranded DNA constructs and non-coated, single- and double-stranded DNA constructs. Using conventional non-coated, double-stranded DNA constructs, we obtained a transgene integration efficiency of 1.5% (1352 embryos transferred produced 20 transgenic pups). The same double-stranded DNA constructs coated with recombinase A protein yielded a similar percentage of transgene integration (1.1%, 18/1697). Using single-stranded DNA, non-coated constructs produced a transgene integration rate of 0.5%, while none of the 1040 zygotes injected with recombinase A-coated constructs produced transgenic pups. While recombinase A protein coating produced no effect on embryo survival, litter size or pregnancy rate with double-stranded constructs, a detrimental effect was observed on embryo survival (P < 0.001) and pregnancy rate (P < 0.005) with recombinase A protein coating of single-stranded human lysozyme DNA constructs. A trend toward increased embryo survival (P = 0.054) with no difference in pregnancy rate (P > 0.05) was observed with the recombinase A protein coating of single-stranded desaturase constructs. These results suggest that recombinase A protein coating of single- and double-stranded DNA constructs produced no significant differences (P > 0.05) in the efficiency of generating transgenic mice with respect to the percentage of transgenic animals born.     

Isolation of yellow catfish β-actin promoter and generation of transgenic yellow catfish expressing enhanced yellow fluorescent protein

Yellow catfish (Pelteobagrus fulvidraco Richardson) is one of the most important freshwater farmed species in China. However, its small size and slow growth rate limit its commercial value. Because genetic engineering has been a powerful tool to develop and improve fish traits for aquaculture, we performed transgenic research on yellow catfish in order to increase its size and growth rate. Performing PCR with degenerate primers, we cloned a genomic fragment comprising 5'-flanking sequence upstream of the initiation codon of β-actin gene in yellow catfish. The sequence is 1,017?bp long, containing the core sequence of proximal promoter including CAAT box, CArG motif and TATA box. Microinjecting the transgene construct Tg(beta-actin:eYFP) of the proximal promoter fused to enhanced yellow fluorescent protein (eYFP) reporter gene into zebrafish and yellow catfish embryos, we found the promoter could drive the reporter to express transiently in both embryos at early development. Screening the offspring of five transgenic zebrafish founders developed from the embryos microinjected with Tg(ycbeta-actin:mCherry) or 19 yellow catfish founders developed from the embryos microinjected with Tg(beta-actin:eYFP), we obtained three lines of transgenic zebrafish and one transgenic yellow catfish, respectively. Analyzing the expression patterns of the reporter genes in transgenic zebrafish (Tg(ycbeta-actin:mCherry)nju8/+) and transgenic yellow catfish (Tg(beta-actin:eYFP)nju11/+), we found the reporters were broadly expressed in both animals. In summary, we have established a platform to make transgenic yellow catfish using the proximal promoter of its own β-actin gene. The results will help us to create transgenic yellow catfish using "all yellow catfish" transgene constructs.     

Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits

Transgenic rabbits carrying gene constructs encoding human nerve growth factor beta (hNGF-beta) cDNA were generated. Expression of hNGF-beta mRNA was restricted to the mammary gland of lactating rabbits. Western Blot analysis revealed a polypeptide of 13.2 kDa in the milk of transgenic animals. hNGF-beta was purified from the milk by a two-step chromatographic procedure. Electrospray mass spectroscopy analysis of purified hNGF-beta depicted a molecular weight of 13,261 Da per subunit. The biological activity of the hNGF-beta was tested using PC12W2 cells and cultures of dorsal root ganglion neurons from chicken embryos. Crude defatted milk from transgenic animals and purified hNGF-beta demonstrated full biological activity when compared to commercial recombinant hNGF-beta.     

Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection.

An important aspect of gene transfer into farm animals is the improvement of disease resistance. The mouse Mx1 protein is known to be sufficient to confer resistance to influenza viruses. Gene constructs containing the mouse Mx1 cDNA controlled by the human metallothionein IIA promoter (hMTIIA::Mx), the SV40 early enhancer/promoter region (SV40::Mx) and the mouse Mx1 promoter (mMx::Mx) were transferred into pigs. The results of the gene transfer experiments with the hMTIIA::Mx and the SV40::Mx constructs indicate that the permanent high-level synthesis of Mx1 might be deleterious to the organism: the gene transfer efficiency was surprisingly low, and all transgenic piglets born had rearrangements in their transgene copies that abolished protein synthesis. The use of the interferon (IFN)- and virus-inducible mMx::Mx construct resulted in normal gene transfer efficiency. Two transgenic pig lines could be established which expressed IFN-inducible mouse Mx1 mRNA. Extensive protein analysis did not detect mouse Mx1 in IFN-treated transgenic animals.     

Myostatin gene silencing by RNA interference in chicken embryo fibroblast cells

Myostatin (MSTN), a member of transforming growth factor-β (TGF-β) superfamily, is a negative regulator of the skeletal muscle growth, and suppresses the proliferation and differentiation of myoblast cells. Dysfunction of MSTN gene either by natural mutation or genetic manipulation (knockout or knockdown) has been reported to interrupt its proper function and to increase the muscle mass in many mammalian species. RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) has become a powerful tool for gene knockdown studies. In the present study transient silencing of MSTN gene in chicken embryo fibroblast cells was evaluated using five different shRNA expression constructs. We report here up to 68% silencing of myostatin mRNA using these shRNA constructs in transiently transfected fibroblasts (p<0.05). This was, however, associated with induction of interferon responsive genes (OAS1, IFN-β) (3.7-64 folds; p<0.05). Further work on stable expression of antimyostatin shRNA with minimum interferon induction will be of immense value to increase the muscle mass in the transgenic animals.     

Somatotropic and lactotropic receptors in transgenic mice expressing human or bovine growth hormone genes

The somatotropic and lactotropic receptors were studied in liver microsomal preparations from transgenic mice carrying the human growth hormone (hGH) or bovine growth hormone (bGH) gene fused to mouse metallothionein-I (MT) or phosphoenolpyruvate carboxykinase promoter/regulator (PEPCK). Specificity studies indicated that, similarly to normal mice, liver microsomes from the transgenic animals possess a mixed population of somatotropic and lactotropic binding sites. In transgenic animals of both sexes, the binding capacity of somatotropic receptors was significantly increased without corresponding changes in affinity. Expression of the MT-hGH hybrid gene was associated with the induction of somatotropic receptors which was approximately twice as great as that measured in animals expressing the MT-bGH hybrid gene. The binding capacity of lactotropic receptors in liver microsomes (quantitated, by the use, of labelled ovine prolactin) was increased 2–3 fold in transgenic females and approximately 10-fold in transgenic males as compared to the respective normal controls. We conclude that lifelong excess of GH up-regulates hepatic GH and prolactin receptors, and that lactogenic activity of GH is not essential for induction of prolactin receptors in the liver of transgenic mice.